nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptive Biomarker Population Selection in Phase III Confirmatory Trials with Time-to-Event Endpoints
|
Li, Xiaoyun |
|
2016 |
10 |
2 |
p. 324-341 |
artikel |
2 |
A New Overall-Subgroup Simultaneous Test for Optimal Inference in Biomarker-Targeted Confirmatory Trials
|
Belitskaya-Lévy, Ilana |
|
2016 |
10 |
2 |
p. 297-323 |
artikel |
3 |
Auto-adaptive Alpha Allocation: A Strategy to Mitigate Risk on Study Assumptions
|
Shentu, Yue |
|
2017 |
10 |
2 |
p. 342-356 |
artikel |
4 |
Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-Event Endpoint
|
Yin, Guosheng |
|
2017 |
10 |
2 |
p. 420-438 |
artikel |
5 |
Bayesian Design of Non-inferiority Clinical Trials Via the Bayes Factor
|
Li, Wenqing |
|
2017 |
10 |
2 |
p. 439-459 |
artikel |
6 |
Biomarker-Defined Subgroup Selection Adaptive Design for Phase III Confirmatory Trial with Time-to-Event Data: Comparing Group Sequential and Various Adaptive Enrichment Designs
|
Tang, Rui |
|
2017 |
10 |
2 |
p. 371-404 |
artikel |
7 |
Efficiency Considerations for Group Sequential Designs with Adaptive Unblinded Sample Size Re-assessment
|
Liu, Lingyun |
|
2017 |
10 |
2 |
p. 405-419 |
artikel |
8 |
Estimating Treatment Effects for Recurrent Events in the Presence of Rescue Medications: An Application to the Immune Thrombocytopenia Study
|
Gao, Fei |
|
2016 |
10 |
2 |
p. 473-489 |
artikel |
9 |
For the Special Issue on Statistical Methods for Clinical Trials and Precision Medicine
|
|
|
2018 |
10 |
2 |
p. 281-282 |
artikel |
10 |
Key Aspects of Modern, Quantitative Drug Development
|
Gibson, Eric |
|
2018 |
10 |
2 |
p. 283-296 |
artikel |
11 |
Population-Enrichment Adaptive Design Strategy for an Event-Driven Vaccine Efficacy Trial
|
Su, Shu-Chih |
|
2017 |
10 |
2 |
p. 357-370 |
artikel |
12 |
Some Recent Advances on Statistical Approaches for Planning Multi-regional Clinical Trials
|
Hung, H. M. James |
|
2017 |
10 |
2 |
p. 460-472 |
artikel |